FORTY SEVEN

forty-seven-logo

Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways based on technology licensed from Stanford University. Forty Seven's lead program, 5F9, is a monoclonal antibody against the CD47 receptor, a "don't eat me" signal that cancer cells commandeer to avoid being ingested by macrophages. This antibody is currently being evaluated in six clinical studies in patients with solid tumors, acute myeloid leukemia, non-Hodgkin's lymphoma and colorectal carcinoma.
#People #Financial #Website #More

FORTY SEVEN

Social Links:

linkedin

Linkedin

Industry:
Biotechnology Clinical Trials Health Care

Founded:
2015-01-01

Address:
Palo Alto, California, United States

Country:
United States

Website Url:
http://www.fortyseveninc.com

Total Employee:
51+

Status:
Closed

Contact:
650-352-4150

Email Addresses:
[email protected]

Total Funding:
156 M USD

Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA Microsoft Azure DNS COVID-19 ReCAPTCHA V2 Pound Sterling



Current Advisors List

dennis-henner_image

Dennis Henner Board Member @ Forty Seven
Board_member
2015-01-01

ian-clark_image

Ian Clark Board Member @ Forty Seven
Board_member
2018-01-01

irving-l-weissman_image

Irving L. Weissman Board Member @ Forty Seven
Board_member
2015-01-01

Current Employees Featured

irving-l-weissman_image

Irving L. Weissman
Irving L. Weissman Founder @ Forty Seven
Founder
2014-10-14

jens-peter-volkmer_image

Jens-Peter Volkmer
Jens-Peter Volkmer Founder & VP Research & Early Development @ Forty Seven
Founder & VP Research & Early Development

mark-mccamish_image

Mark McCamish
Mark McCamish President and Chief Executive Officer @ Forty Seven
President and Chief Executive Officer
2017-05-01

norman-kruse_image

Norman Kruse
Norman Kruse Chief Patent Counsel @ Forty Seven
Chief Patent Counsel
2015-10-01

ravi-majeti_image

Ravi Majeti
Ravi Majeti Founder @ Forty Seven
Founder
2015-01-01

ann-d-rhoads_image

Ann D. Rhoads
Ann D. Rhoads Chief Financial Officer @ Forty Seven
Chief Financial Officer

Founder


irving-l-weissman_image

Irving L. Weissman

jens-peter-volkmer_image

Jens-Peter Volkmer

mark-chao_image

Mark Chao

ravi-majeti_image

Ravi Majeti

Stock Details


Company's stock symbol is NASDAQ:FTSV

Investors List

leukemia-lymphoma-society_image

Leukemia & Lymphoma Society

Leukemia & Lymphoma Society investment in Post-IPO Equity - Forty Seven

wellington-management_image

Wellington Management

Wellington Management investment in Series B - Forty Seven

sutter-hill-ventures_image

Sutter Hill Ventures

Sutter Hill Ventures investment in Series B - Forty Seven

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Series B - Forty Seven

google-ventures_image

GV

GV investment in Series B - Forty Seven

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series B - Forty Seven

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series A - Forty Seven

sutter-hill-ventures_image

Sutter Hill Ventures

Sutter Hill Ventures investment in Series A - Forty Seven

google-ventures_image

GV

GV investment in Series A - Forty Seven

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Series A - Forty Seven

Official Site Inspections

http://www.fortyseveninc.com

  • Host name: 40.70.27.35
  • IP address: 40.70.27.35
  • Location: Boydton United States
  • Latitude: 36.6534
  • Longitude: -78.375
  • Metro Code: 560
  • Timezone: America/New_York
  • Postal: 23917

Loading ...

More informations about "Forty Seven" on Search Engine

dfkcompany.com © 2022. All rights reserved